BLPH's logo.
Ticker Symbol: BLPH

Bellerophon Therapeutics Inc

$3.59 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001600132

Company Profile

bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 184 Liberty Corner Rd Ste 302
CEO: Fabian Tenenbaum
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $0.10
Change: -$0.28 ( -73.39%)
Days Range: $0.05 - $0.10
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change -73.39%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 12232648

Valuation

Market Cap: 125.4M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A